What SmartStep does

SmartStep Consulting GmbH is a Hamburg, Germany-based professional services firm founded in 2010 that provides highly specialized consulting to the pharmaceutical, vaccine, and biotech industries. The firm targets enterprise clients across these verticals and is organized to help them accomplish, defend, or sustain fast and efficient market access for their products within the German and broader European healthcare system. The company operates as a unified consulting practice rather than a software platform; its productive technology is human domain expertise rather than proprietary code, and no AI/ML capabilities, APIs, or productized software assets are disclosed.

The firm's commercial offering comprises three interconnected service lines: Healthcare Strategy Consulting (multi-faceted market strategy development), Market Access Consulting (navigation of HTA, AMNOG, and DRG regulatory frameworks), and Stakeholder Management & Negotiation (early-stage engagement with payers, policymakers, and other healthcare system stakeholders). Pricing is not publicly disclosed and is consistent with project-based, quote-driven engagements typical of boutique professional services.

Go-to-market is sales-led and executed through direct consulting relationships with pharmaceutical, biotech, and vaccine companies. Demand generation relies on a LinkedIn company page, owned website content (publications and blog), and industry event participation. The company maintains a single Hamburg headquarters, has 11–50 employees, is part of the broader G&L Group of Companies network, has no disclosed funding events, and discloses no named customers, certifications, patents, or awards. Operating status is active based on current website content, event listings, and vacancy postings.

Name

SmartStep

Legal name

SmartStep Consulting GmbH

Website

https://smartstep-consulting.de

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

SmartStep Consulting GmbH is a Hamburg-based boutique consultancy serving pharmaceutical, vaccine, and biotech clients with specialized healthcare strategy, market access (HTA, AMNOG, DRG), and stakeholder management services across Germany and Europe.

Ownership category

akta.pro rank

Product category

Healthcare Consulting Services

NAICS

Management Consulting Services (54161)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Strategy & Corporate Development Consulting (BPAHACAA)

akta.pro secondary industry

Organization Design & Operating Model Consulting (BPAHAGAB)

Keywords

• Healthcare consulting services
• Pharmaceutical market access
• Biotech strategy consulting
• AMNOG HTA consulting
• Vaccine market access

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Healthcare Consulting Services: The company generates revenue through specialized consulting engagements for pharmaceutical, vaccine, and biotech companies seeking market access strategy, healthcare strategy, and stakeholder management services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

SmartStep Consulting GmbH provides highly specialized consulting services to pharmaceutical, vaccine, and biotech companies, focused on achieving, defending, or sustaining fast and efficient Market Access for their products. Its core offerings include Healthcare Strategy Consulting, Market Access Consulting (HTA, AMNOG, DRG navigation), and Stakeholder Management & Negotiation preparation.

Product overview

SmartStep is a consulting firm offering highly specialized and individualized consulting services for the pharmaceutical, vaccine, and biotech industry. The company operates as a unified consulting practice rather than a software platform. Its core service portfolio consists of three interconnected consulting offerings: Healthcare Strategy Consulting (addressing market strategies and challenges), Market Access Consulting (ensuring optimal market success through HTA, AMNOG, and DRG navigation), and Stakeholder Management & Negotiation (optimizing stakeholder engagement and negotiation preparation). These services work together to help clients accomplish, defend, or sustain fast and efficient market access for their products.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Strategy Consulting

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• G&L Group of CompaniesOthersSmartStep Consulting GmbH is part of the G&L Group of Companies, a healthcare consulting and services group. SmartStep operates as a specialized healthcare strategy and market access consulting firm within this group.

Recent moves5 records

Expansion highlights3 records

Direct peers

• Ecker + Ecker: Hamburg/Germany-based consultancy focused on pharma market access, HTA, AMNOG and pricing — virtually identical service scope to SmartStep, making it the closest head-to-head competitor in the German market access niche.
• SKC Beratungsgesellschaft: German consultancy specializing in pharmaceutical market access, AMNOG, HTA and pricing strategy for the German healthcare market, directly overlapping with SmartStep's core offering.
• Simon-Kucher & Partners: Global strategy consulting firm with a strong Life Sciences practice focused on pricing, market access and commercial strategy for pharma and biotech — same buyer (pharma market access leads), overlapping methodology.
• ZS Associates: Global management consulting firm dedicated to pharma and biotech with deep market access, pricing and HTA capabilities, serving the same large-pharma buyer set as SmartStep.
• Health Advances: Healthcare strategy consulting firm advising biopharma and medtech clients on market access, pricing and commercial strategy — comparable boutique-to-mid-market positioning in life sciences advisory.

Broad incumbents

• A.T. Kearney (Healthcare Practice): Global management consultancy with a healthcare strategy practice that competes for pharma market access and commercial strategy engagements from a much broader portfolio perspective.
• IQVIA: Global life sciences services and consulting firm offering end-to-end market access, HTA, RWE and commercial strategy — overlaps with SmartStep on the market access buyer but at vastly greater scale and breadth.
• McKinsey & Company (Healthcare Practice): Global strategy consultancy whose healthcare/pharma practice advises on market access, commercial strategy and corporate strategy, often competing for the same pharma strategy engagements as SmartStep at the senior end.
• Bain & Company (Healthcare Practice): Global strategy consulting firm with a strong healthcare and life sciences practice covering market access, commercial and corporate strategy — overlaps on pharma market access buyer and engagement types.

Emerging players

• LSCN – Life Sciences Strategy Consulting Network: Network of boutique life sciences consulting firms with similar pharma strategy and market access profiles; comparable to SmartStep in size and focus but operates as a federated network rather than a single firm.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/smartstep-consulting

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SmartStep